Similar to pancreatic cancer, in which a higher preoperative CA 19-9 was associated with surgical-related muscle loss [22], we have discovered that a more advanced HCC in terms of AFP or tumor size could also result in more pronounced muscle loss after surgery. The gene discussed is AFP; the disease is hepatocellular carcinoma.